an experimental vaccine can alter the immune response of people infected with the aids virus , a prominent u.s. scientist said 0 . however , that does n't mean 0 they can benefit from the vaccine . its effectiveness ca n't be determined until a large clinical trial is undertaken by the army in january , according to robert redfield , chief of acquired immune deficiency syndrome research at walter reed army institute of research . dr. redfield 's report on early experiments using an aids vaccine made by microgenesys inc. of west haven , conn. , came at a meeting of aids vaccine researchers in florida late monday . the vaccine , vaxsyn hiv-1 , has been safely given to 14 people , some of whom are experiencing substantial increases in certain antibodies . `` the conventional wisdom used to be that you could n't modify the immune response of an infected individual '' by innoculating them with synthetic viral proteins , dr. redfield said 0 . `` we 've demonstrated that you can . '' he said 0 certain volunteers developed kinds of antibodies associated with early aids . other antibodies sparked by the preparation are of a sort rarely present in large quantities in infected or ill individuals , he added 0 . one of the mysteries of aids remains why infected people produce large quantities of antibodies , but deteriorate nonetheless .